Sorry, link does not work
Things starting to add up
CELLMID US, EURO MIDKINE PATENTS CELLMID Cellmid says it has received US and European patents for improved midkine antibodies, which will protect its intellectual property until October 14, 2035. ... volunteers and idiopathic pulmonary fibrosis-interstatial lung disease patients.
Biotech back issue.
We are OK to 2035 by the looks on this one.
"Target Corona (COVID19) - Midkine is where the fire is coming from", page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 214857 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 289915 | 2 |
View Market Depth
| Last trade - 16.12pm 26/07/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable